Article Details

TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock

Retrieved on: 2019-02-13 09:30:00

Tags for this article:

Click the tags to see associated articles and topics

TCR2 Therapeutics Announces Pricing of Initial Public Offering of Common Stock. View article details on hiswai:

Excerpt

<div>The Company has also granted the underwriters a 30-day option to purchase from the Company up to an additional 750,000 shares of common <b>stock</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up